Concept and design of a nationwide prospective feasibility/efficacy/safety study of weekly paclitaxel for patients with pathologically confirmed anaplastic thyroid cancer (ATCCJ-PTX-P2)

Anaplastic thyroid cancer (ATC) is one of the most aggressive malignancies in humans, often demonstrating resistance to multimodal therapeutic approaches. The median survival of ATC patients after initial diagnosis was reported to be

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	BMC cancer 2015-06, Vol.15 (1), p.475-475, Article 475
Hauptverfasser:	Onoda, Naoyoshi, Sugitani, Iwao, Higashiyama, Takuya, Hara, Hisato, Ito, Ken-ichi, Kammori, Makoto, Sugino, Kiminori, Suzuki, Shinichi, Toda, Kazuhisa, Yoshida, Akira, Miyauchi, Akira
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Cancer Care and treatment Chemotherapy Development and progression Drug therapy Feasibility Studies Female Health aspects Humans Japan Male Middle Aged Neoplasm Staging Paclitaxel - administration & dosage Prognosis Study Protocol Thyroid cancer Thyroid Carcinoma, Anaplastic - drug therapy Thyroid Carcinoma, Anaplastic - epidemiology Thyroid Carcinoma, Anaplastic - pathology Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Anaplastic thyroid cancer (ATC) is one of the most aggressive malignancies in humans, often demonstrating resistance to multimodal therapeutic approaches. The median survival of ATC patients after initial diagnosis was reported to be
ISSN:	1471-2407 1471-2407
DOI:	10.1186/s12885-015-1490-8